Camelidae and Cervidae Neonatal Septicemia Study Guide

Overview and Clinical Importance

Neonatal septicemia is a life-threatening systemic inflammatory response to bacterial infection that represents one of the most significant causes of morbidity and mortality in neonatal camelids (llamas and alpacas, collectively called crias) and cervids (deer fawns and elk calves). This condition occurs most commonly within the first 2 weeks of life and is strongly associated with failure of passive transfer (FPT) of maternal immunoglobulins via colostrum.

In camelids, septicemia accounts for a substantial proportion of neonatal deaths, with studies reporting that approximately 22% of hospitalized neonatal crias are culture-positive for bacteremia. Similarly, cervid neonates in captive settings are highly susceptible to septicemia, particularly when colostrum management is inadequate. Understanding the pathophysiology, clinical presentation, diagnostic approach, and treatment of neonatal septicemia is essential for the NAVLE and BCSE examinations.

Pathophysiology

Failure of Passive Transfer (FPT)

Camelids and cervids, like all ruminants and pseudoruminants, have an epitheliochorial placenta that prevents transplacental transfer of immunoglobulins. Neonates are born agammaglobulinemic (without circulating antibodies) and are entirely dependent on absorbing maternal immunoglobulins from colostrum within the first 12-24 hours of life.

The neonatal gut has specialized enterocytes capable of non-selective macromolecular absorption (pinocytosis) that allows IgG absorption. This absorptive capacity decreases rapidly after birth, with gut closure occurring by 18-24 hours in most species.

Causes of Failure of Passive Transfer

Species-Specific IgG Thresholds

Bacterial Pathogens

The most common pathogens causing neonatal septicemia are gram-negative bacteria, particularly Escherichia coli, which accounts for 60-70% of cases. Other important pathogens include:

• Escherichia coli (most common)
• Salmonella species
• Klebsiella pneumoniae
• Enterobacter species
• Streptococcus species
• Staphylococcus aureus
• Listeria monocytogenes (rare but reported in camelids)
• Pasteurella multocida (hemorrhagic septicemia in cervids)

Routes of Infection

Clinical Signs and Presentation

Clinical signs of neonatal septicemia are often nonspecific and subtle in early stages. Owners may initially report only that the neonate "isn't doing right" or "won't nurse." Rapid recognition and intervention are critical for survival.

Clinical Signs by System

Camelid-Specific Considerations

Choanal atresia: This congenital defect (failure of the inner nares to open) is the most common congenital abnormality in camelids. Because camelids are obligate nasal breathers, affected crias present with respiratory distress that worsens during nursing. These crias often aspirate milk and develop secondary pneumonia and septicemia.

Metabolic abnormalities: Septic crias commonly develop hyperglycemia, hypernatremia, and hyperosmolarity. This "hyperosmolar syndrome" is relatively unique to camelids and complicates fluid therapy.

Normal birth weights: Alpaca crias: 12-20 lbs (average 15-16 lbs); Llama crias: 18-35 lbs (average 20s). Premature crias are often smaller and more susceptible to FPT and septicemia.

Cervid-Specific Considerations

Handling stress: Cervids are highly susceptible to capture myopathy and stress-induced mortality. Minimize handling and use appropriate sedation/anesthesia when necessary.

Pasteurella multocida: Hemorrhagic septicemia caused by P. multocida serotypes B:2 and E:2 can cause peracute mortality in cervids, particularly in stressed or immunocompromised animals.

Epizootic Hemorrhagic Disease (EHD): While viral (orbivirus), EHD can present with hemorrhagic signs similar to septicemia. It is important to differentiate as it is not treatable with antimicrobials.

Diagnosis

Early diagnosis of septicemia is challenging but critical. A presumptive diagnosis is often made based on clinical presentation and risk factors, and treatment should be initiated immediately while awaiting laboratory confirmation.

Diagnostic Tests

Treatment

Treatment of neonatal septicemia requires an aggressive, multimodal approach including antimicrobial therapy, supportive care, fluid therapy, and often plasma transfusion. Early intervention significantly improves survival rates.

Antimicrobial Therapy

Begin broad-spectrum, bactericidal antimicrobials immediately. The initial choice should cover gram-negative organisms (most common) while also addressing gram-positive possibilities. Combination therapy is preferred.

Fluid Therapy

Fluid therapy corrects dehydration, improves perfusion, and supports organ function. Camelid neonates require special consideration due to their tendency toward hyperglycemia and hypernatremia.

• Initial bolus: 30-40 mL/kg isotonic crystalloids (normal saline or Plasma-Lyte) over 1-2 hours
• Maintenance rate: Up to 100 mL/kg/day (lower than other species)
• Camelid caution: Avoid glucose-containing fluids unless hypoglycemic; monitor for hypernatremia and hyperosmolarity
• If hyperosmolar: Use diluted fluids (0.45% saline with sterile water) and correct slowly

Plasma Transfusion

Plasma transfusion is indicated for neonates with FPT (IgG less than 1,000 mg/dL in camelids, less than 1,600 mg/dL in cervids/ruminants) and is highly recommended for septic neonates even with borderline IgG levels.

• Volume: 20-30 mL/kg IV over 1-2 hours
• Route: Intravenous preferred; intraperitoneal is less effective and has more complications
• Source: Species-specific plasma preferred (llama/alpaca plasma for crias); bovine plasma can be used for cervids
• Monitoring: Watch for transfusion reactions; recheck IgG 12-24 hours post-transfusion

Additional Supportive Care

Prognosis

Survival rates for septic neonates vary widely depending on early recognition and treatment. Studies report survival rates of 45-78% for hospitalized neonatal camelids with septicemia when treated aggressively.

Negative prognostic indicators:

• Hypothermia (worse than fever)
• Severe neutropenia with degenerative left shift
• Meningitis or CNS involvement
• Multiple organ involvement
• Persistent hyperlactatemia
• Delayed treatment initiation

Prevention

Prevention of neonatal septicemia focuses on ensuring adequate passive transfer through proper colostrum management and minimizing environmental pathogen exposure.

Colostrum Management Protocol

• Ensure early first nursing: Observe neonate standing and nursing within 1-2 hours of birth
• Assess colostrum quality: Use Brix refractometer (greater than 22% = good quality)
• Provide adequate volume: 10-20% of body weight in colostrum within first 12-24 hours
• Supplement if needed: Tube-feed colostrum if weak suckle; use species-appropriate colostrum or replacer
• Verify passive transfer: Check IgG or total protein at 24-48 hours of age

Environmental and Management Measures

• Maintain clean, dry birthing area with fresh bedding
• Dip umbilicus in 7% tincture of iodine or 0.5% chlorhexidine within 15 minutes of birth and repeat at 2-4 hours
• Monitor dams for adequate milk production and maternal behavior
• Weigh neonates daily for first 1-2 weeks to ensure appropriate weight gain
• Implement dam vaccination programs for pathogen-specific colostral antibodies